SCN5A

Chr 3ARAD

sodium voltage-gated channel alpha subunit 5

OMIMResearchGenerating clinical summary…
MultiplemechanismAR/ADLOEUF 0.319 OMIM phenotypes
Clinical SummarySCN5A
🧬
Gene-Disease Validity (ClinGen)
arrhythmogenic right ventricular cardiomyopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

4 total gene-disease associations curated

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.91). One damaged copy is likely sufficient to cause disease.
Some data sources returned errors (1)

ncbi: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.31LOEUF
pLI 0.913
Z-score 6.70
OE 0.21 (0.140.31)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.75Z-score
OE missense 0.78 (0.740.82)
967 obs / 1239.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.21 (0.140.31)
00.351.4
Missense OE?0.78 (0.740.82)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 17 / 82.8Missense obs/exp: 967 / 1239.5Syn Z: 0.34
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSCN5A-related long QT syndromeGOFAD
definitiveSCN5A-related Brugada syndromeLOFAD
limitedSCN5A-related arrhythmogenic right ventricular cardiomyopathyOTHERAD
definitiveSCN5A-related dilated cardiomyopathyOTHERAD

This gene — mechanism propensity

DN
0.6744th %ile
GOF
0.81top 10%
LOF
0.3842th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF1 literature citation · LOEUF 0.31 · ClinGen HI: Sufficient evidence for dosage pathogenicity
GOFprediction above median · 1 literature citation
DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNIn co-expression experiments, L325R channels interfered with the proper function of WT channels, suggesting that a dominant negative phenomenon may underlie BrS triggered by fever.1
GOFA heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.2
LOFThey also demonstrate that haploinsufficiency of SCN5A is associated with increased accumulation of reactive oxygen species (ROS) in a genetically engineered murine model.3

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SCN5A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →